A live eight-foot snake has been found in a cardboard box sent from Harlow to Exeter by post.

The albino reticulated python was spotted through an X-Ray machine at Stansted Airport, where it was due to be put onto a plane last Friday to complete its journey. The reptile is commonly kept as a pet and had already spent eight hours in the postal system.

As Royal Mail will not allow the transport of live animals by post, RSPCA inspector Steve Reeves was called to rescue the snake. He said: "It may sound strange, but it would have been easy to miss the fact that there was such a large snake in this parcel. It was just curled up and was very still - so the mailmen picking up the parcel would have had no reason to know what was inside.

"All the machine picked up was that there was something organic in the shape of a snake - so they must have got quite a shock when they opened up the package. It makes you wonder what could go undetected."

Luckily this snake was unharmed, and was taken to a wildlife centre in Essex while its owner was traced. It had been bought via the internet and the new owner has since organised for a specialist courier to pick the snake up.

Scientists from the Animal Health Trust, the Wellcome Trust Sanger Institute and the University of St. Andrews have pinpointed the genes which allow the bacteria responsible for strangles to thrive, thereby paving the way for the development of a vaccine.

In the study, which the researchers say was the largest of its kind, 224 samples of Streptococcus equi (S. equi) were procured from horses around the globe to try and find a common bacterial ancestor from which modern strains would have developed. Despite the disease first being described in 1251, the researchers were surprised at the genetic similarity of the samples and identified a total population replacement at the 19^th or early 20^th century. This corresponds to a period when horses from around the world were brought together in global conflicts including World War I, where an estimated eight million horses died on the battlefield.

Dr Simon Harris from the Wellcome Trust Sanger Institute said: “The mobilisation and mixing of horses in conflicts such as WWI provided perfect conditions for S. equi to thrive. This combined with high mortality rates among the horses and their replacement with young susceptible horses could explain what we see around the world today".

While loss of diversity could be considered detrimental to bacterial populations, S. equi still infects more than 20,000 horses in the UK alone each year. Its success, researchers believe, is due to its ability to persist in some horses for years after they have recovered from strangles, where the bug can evolve to evade the horse’s immune system.

Dr Andrew Waller, Head of Bacteriology at the Animal Health Trust said: “The data we have gathered in this study has enabled us to pinpoint the genes that help the bacteria to persist, spread and thrive in the horse population. This research provides an unprecedented opportunity to reduce the impact of and prevent strangles in future generations of horses.”

The AHT says that the ability of S. equi to adapt to living in a persistent state within its host and still infect new horses mirrors the situation with HIV and the bacteria that causes tuberculosis in humans. Dr Matthew Holden from the Wellcome Trust Sanger Institute and the University of St Andrews said: “Unravelling the complex population dynamics of S. equi sheds new light on the balancing act between acute and persistent infection that is going on in many pathogens. Not only does this collection of whole-genome sequences for S. equi offer hope for an effective strangles vaccine, it also provides us with a useful model for understanding persistent infection in humans.”

Dechra has launched a new administration rate guide developed to help vets and nurses administer the haemoglobin-based, oxygen-carrying fluid Oxyglobin at the correct rate (in ml/kg/hr).

"The handy dosing wheel allows you to line up the weight of the dog with the rate of administration in one window and then the ml/hr and drips per minute will be shown in the window below," explains Carol Morgan, product manager at Dechra Veterinary Products. "This rate guide will help vets and nurses to quickly establish the rate they need when giving Oxyglobin to anaemic dogs. It is important, especially during critical care and emergency situations, that these figures are readily available." 

According to Dechra, Oxyglobin requires no typing or cross-matching and ensures no transfusion reactions or disease transmissions. Its effectiveness can be measured by a rapid improvement in clinical signs, increased plasma haemoglobin concentration and arterial oxygen content. In addition, it can be stored at room temperature and has a shelf-life of three years. Further details can be obtained from Dechra territory managers or phone for your free Oxyglobin dosing wheel: 01743 441 632. 

Market research company Bax Interaction has made a last call for veterinary surgeons to take part in a survey about parasite control practices for beef cattle - with a chance to win a £500 cash prize.

The research aims to establish:

• which products and methods being used to treat fluke, worms and external parasites, and the reasons for selecting them
• the key factors in the decision to buy or recommend parasiticides
• what issues are currently being experienced with parasite control, and market needs for future. 

To take part in the survey, which takes between 10 and 15 minutes, click here.

Photo: I, Flukeman

The Information Commissioner has supported the Royal College of Veterinary Surgeons' decision not to publish the Overspend Review Group's report (aka the McKelvey Report) in full.

The verdict follows two challenges to the College's decision, one made by the British Veterinary Association and a second by a member of the College.

The College says its original decision not to publish the report in full was based on two sets of external legal advice that to do so would be unlawful under the provisions of the Data Protection Act. However, the College did publish the recommendations from the report (otherwise known as the McKelvey Report), which it says comprise more than half of the total.

The Overspend Review Group was tasked with considering all aspects that relate to the College's budgeting and expenditure processes and to propose lessons that should be learned. It was set up following overspends in two areas: the installation of a new data management system and building development work at the College's premises in London.  

RCVS President Jacqui Molyneux said: "This verdict is welcome in that it supports our original decision. But I can appreciate that it may frustrate those members unhappy that they will not see the full report.

"When it was commissioned, it was intended that the report would be published in full; in the event, the document included information that would contravene the Data Protection Act if published. However, I would like to reassure members that the substance of the report was included in the published recommendations, and these have now, in the main, been acted upon."

Questions and answers about the Report, together with the recommendations, can be found here.

Improve International is offering six subscriptions each day to its Online Bitesize CPD training programme on its stand – D25 - at the London Vet Show.

Visitors will have the opportunity to test their knowledge in a short quiz with three veterinary surgeons and three nurses winning each day.

Online Bitesize CPD is a training programme for veterinary professionals wanting to gain skills and knowledge in key clinical subjects. The training is interactive with each course accredited by the European School of Veterinary Postgraduate Studies (ESVPS).  It provides the mandatory CPD hours for veterinary surgeons and nurses in a single subscription.

David Babington, Improve International’s Managing Director, said: "Our Bitesize CPD offers complete flexibility so that vets and vet nurses can access our high quality learning on clinical topics in short 'chunks', at a time and place to suit them. Courses are updated regularly and cover topics including: soft tissue surgery, ophthalmology and feline medicine for vets and fluid therapy, critical care and anaesthesia for nurses.

"We’ve devised a fiendish London Vet Show quiz to put visitors through their paces and will announce the six lucky winners of a year’s free subscription for each day at the end of the show!"

'Get Well Friends', a new retail opportunity for veterinary practices, has now officially launched with a new website: www.getwellfriends.com  

Described by their inventor, childrens' author Kes Gray, as "the ouch factor mixed with the aah factor", Get Well friends are a new and unique range of soft toy poorly animal characters for veterinary surgeries to sell. Each character is as cute as it is accident prone, and comes complete with a prescription from mouse Nurse Nibbles.

"For all kinds af reasons a young child may have to leave their pet with a vet. Under such circumstances, they can now depart from the surgery with a soft toy animal character that they themselves can nurse back to good health."

The Get Well Friends.com website has been set up to try and lower the blood pressure of long suffering veterinary waiting room staff, with online games for children to play and activity sheets for surgeries to print off.

First shown at the London Vet Show, the current gift range comprises 5 soft toy characters and a 'childrens picture book entitled 'Who's Poorly Too?' The recommended retail price for each 8" soft toy characters is £11.99. (Trade price £5.50 per unit not inclusive of Vat.) The 'Who's Poorly Too' paper back picture book has an RRP of £5.99 and a trade price of £3.60 per unit.

Kes Gray's wife and co-founder of Get Well Friends said: "The spinner is our recommended  display method. It has a strong and colourful retail presence. It holds fifteen toys and fifteen picture books, and can be bought for a special intoductory offer price of just £157.50. If a surgery waiting room is pushed for space, we can offer our striking 10 unit counter display boxes, or if preferred we can supply any combination of characters loose."

Click here to download the brochure and trade price list.

If you would like to place an order or make an enquiry contact Kes & Claire direct at info@getwellfriends.com.

Over 1,200 members of the Royal College of Veterinary Surgeons, including around 800 UK-practising veterinary surgeons, have not yet paid their retention fees, and face being removed from the Register if they do not pay before 29 May 2010.

Veterinary surgeons must be registered with the College in order to practise legally in the UK. Retention fees are due by the end of March each year, and the College allows a further two-month period before removing veterinary surgeons from the Register, during which time reminders are issued.

There is still just time for payment to be made by credit card, bank transfer or cheque. Payments cannot be made over the telephone.

Those who have recently changed address, practice address or bank details are urged to check that payments have been properly processed. It is the responsibility of individual members to ensure payment has been made, even if an employer pays the fee. Those whose names are removed for non-payment after 29 May will no longer be able to practise legally in the UK, and would need to pay an additional fee if they wished to be restored to the Register.

Bill Mavir, VDS Chairman said: "Registration with the RCVS is a prerequisite for membership of the Veterinary Defence Society and the provision of professional indemnity insurance."

The British Veterinary Association has reiterated its call for heightened vigilance following confirmation by AHVLA that Schmallenberg virus (SBV) has been detected on four sheep farms in Norfolk, Suffolk and East Sussex.

At this early stage the virus is understood to be vector-borne (although other routes of transmission have not been ruled out) and the clinical signs seen along with meteorological modelling of risk suggests that the four farms were affected during summer/autumn 2011, with congenital defects now becoming visible at lambing time.

Animals imported from the affected areas in northern Europe are also considered to be potentially at risk and their destination in the UK has been identified.

Congenital deformities and nervous defects are seen in newborn lambs, goat kids and calves. Clinical signs in affected cattle include pyrexia (fever), milk drop, and diarrhoea similar to what is often termed 'winter dysentery'. Farmers should be looking out for clusters of these signs within herds and flocks and reporting them to their veterinary surgeon.

Vets who are aware of suspicious clinical signs on their client's farms should report them to AHVLA, SAC or the local DARD divisional veterinary office for further investigation.

AHVLA, SAC and DARD have stated that they are keen to investigate potential cases and there will be no extra charge for the SBV tests that are undertaken, but their approaches are slightly different.

In England, Wales and Northern Ireland AHVLA and AFBI are carrying out SBV-only testing (ie to rule the disease in or out) free of charge but are charging the standard subsidised investigation charge for any additional diagnostic work.

In Scotland any carcases submitted for post mortem examinations are examined at the standard fee and all necessary examinations required by the VIO to investigate the case are included in the fee. SAC is not charging an additional fee for SBV testing.

Carl Padgett, President of the BVA, said:  "The confirmation of Schmallenberg virus in sheep flocks in England is a reminder to vets and farmers across the UK to step up vigilance amongst ruminants.

"The BVA would encourage vets to speak to their local AHVLA, SAC or DARD team to discuss any suspect cases and consider submitting specimens for further investigation. We understand that in confirmed cases clinical signs occur in clusters and vets should ensure they know what to look for in both adult and perinatal ruminants.

"While the cases in the south east of England suggest the virus is vector-borne other potential routes of transmission are still being considered. Although the risk of zoonosis is believed to be very low it has not been ruled out and a sensible precautionary approach should be taken by those handling infected animals and specimens."

According to the European Scientific Counsel for Companion Animal Parasites (ESCCAP), serious zoonotic diseases, currently rife across Europe, could be a far more serious threat to pet and human health in the UK than official figures suggest.

Vets and parasitologists at an ESCCAP meeting held in Bristol on 19th September, heard evidence that UK cases of diseases such as leishmaniosis and babesiosis are grossly under-reported. ESCCAP is urging vets and parasitologists to help raise awareness of the threat and lobby the Government to prevent further relaxation of pet movement restrictions.

According to DACTARI, the voluntary web-based Dog And Cat Travel And Risk Information scheme, just 19 cases of leishmaniosis, 10 babesiosis, 10 ehrlichiosis and one case of dirofilariosis had been recorded between 1 January 2003 and 30 September 2006, which are the latest figures reported on the Defra website.

But latest figures presented by Susan Shaw, senior lecturer in dermatological and applied immunology, revealed a screening programme underway at Bristol University casts serious doubts on the reliability of the Defra-backed service to monitor cases.

"From 2005 to 2007 we recorded 257 cases of leishmaniosis. The babesiosis cases you can multiply by about five, the ehrlichiosis cases by about 10 and dirofilariosis by three," Ms Shaw told delegates at the sixth ESCCAP meeting. "That is absolutely outrageous - we are dealing with a massive number of cases. I would be very concerned if we are making decisions for the UK based on the DACTARI figures."

Maggie Fisher, an independent consultant in veterinary parasitology and founding member of ESCCAP pointed out that the PETS (Pet Travel Scheme), has issued dogs and cats with passports for travel across Europe since 2000 and has proven immensely popular, with 76,000 dogs entering the UK in January to October 2007 alone.

"What is coming into the country with those animals is not well documented," said Mrs Fisher. Case studies point to harrowing experiences for individual families travelling with their dogs to mainland Europe unaware of the dangers. "One family thought they'd done everything they should because they followed the instructions under PETS. What they didn't realise is that they weren't protected against ticks, tick-borne diseases and worms whilst they were away and their dog picked up babesiosis."

Human health and veterinary professionals at the meeting explored the real threat and implications of parasites across Europe. Peter Deplazes of ESCCAP, Switzerland, reported that the human form of Echinococcus multilocularis claims three or four lives per year in Switzerland and is a very common endoparasitic diagnosis in dogs. Forty per cent of foxes are infected with E multilocularis.

Leishmaniosis causes renal failure in dogs, reported ESCCAP Spain's Lupe Miro Corrales, often leading to death or euthanasia. Worldwide more than 12 million people are already infected, and one in ten at risk of being infected. Stray dogs and cats are important carriers and almost 80 per cent of sero-positive dogs have no clinical signs.

Natural controls offered by the UK's island status are now under threat. Currently a derogation allows the UK, and four other EU member states, stricter controls to help maintain their Echinococcus multilocularis and tick-borne disease free status. It extends to July 2010 but comes up for review next year, pointed out Maggie Tomlinson from the Department of Health, who is taking the case to the EU Commission.

"I can say categorically that they are not keen for us to keep the derogation and it's going to be a very hard fight. We only have until January to push the Commission to make a decision."

Chairman-elect of ESCCAP Europe, James Duncan, pointed out the organisation is seeking to raise awareness of the serious risks posed by endo and ecto-parasites to human and animal health, and is developing independent guidelines and educational materials for their optimal control.

"There is no immediate panacea," he said. But those in the veterinary profession who are aware of the risks should take action. "It is up to you to lobby - put your voice to Government and influence the pet passport scheme. You can do that and it will help our cause because we are singing from the same hymn sheet."

Horses suffering from neurological conditions similar to those that affect humans could be helped by a breakthrough from stem cell scientists, according to a study published in the journal Stem Cells and Development.

Researchers at the University of Edinburgh's Roslin Institute took skin cells from a young horse and turned them into stem cells using a technique that was originally developed for human cells. The reprogrammed cells are pluripotent, which means they can be induced to become any type of cell in the body. The team used them to create nerve cells in the laboratory and tested whether they were functional by showing that they could transmit nerve signals in a test tube.

The university says horse stem cells have been produced in the laboratory before but this is the first time that scientists have created working cells of a specific type from them. The advance may pave the way for cell therapies that target conditions similar to motor neurone disease.

In addition, the research could also benefit horses affected by grass sickness, a neurological condition that affects around 600 horses a year in the UK. Little is known about the disease, which causes nerve damage throughout the body. It is untreatable and animals with the most severe form usually die or have to be put down.

Dr Xavier Donadeu from the Roslin Institute, an author of the study, said: "Stem cells hold huge therapeutic potential both for people and animals. Our research is an important step towards realising that potential for horses and provides an opportunity to validate stem-cell based therapies before clinical studies in humans."